SCHEMBL3972900

SCHEMBL3972900

CCOc1cc(CO)ccc1OC

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.54
HTT P42858 1/20 0.54
CALM1 P0DP23 3/20 0.53
CA2 P00918 1/20 0.52
PDE4A P27815 6/20 0.51
PDE4B Q07343 6/20 0.51
PDE4C Q08493 6/20 0.51
PDE4D Q08499 6/20 0.51
NPC1 O15118 1/20 0.50
POLB P06746 1/20 0.50
RAB9A P51151 1/20 0.50
MAPK1 P28482 1/20 0.50
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
ALDH1A1 P00352 1/20 0.48
TSHR P16473 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30714383 0.93 CALM1 (0.61) HTTCALM1CA2NPC1POLB
SCHEMBL579760 0.93 CALM1 (0.61) HTTCALM1CA2NPC1POLB
SCHEMBL697888 0.90 HTT (0.61) HTTCALM1PDE4APDE4DNPC1
Alcohol SCHEMBL8946306 0.86 CA2 (0.63) CA2NPC1POLBRAB9AKDM4E
SCHEMBL119395 0.86 CA2 (0.68) CA2NPC1POLBRAB9AKDM4E
SCHEMBL28170408 0.86 CA2 (0.68) CA2NPC1POLBRAB9AKDM4E
SCHEMBL29997296 0.86 CA2 (0.68) CA2NPC1POLBRAB9AKDM4E
SCHEMBL6798353 0.86 NPSR1 (0.50) CA2NPC1POLBRAB9AMAPT
SCHEMBL11030253 0.85 CALM1 (0.56) L3MBTL1CALM1CA2PDE4APDE4B
SCHEMBL7928047 0.84 PDE4A (0.52) PDE4APDE4BPDE4CPDE4DMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910260-B1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA SPA (IT) 2009-12-16 EP claimed
US-7544843-B2 Process for preparing 3,4-dioxo-substituted aromatic aldehydes ENDURA S.P.A. (IT) 2009-06-09 US claimed
US-20090062569-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.P.A. (IT) 2009-03-05 US claimed
EP-1910260-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.p.A. (IT) 2008-04-16 EP claimed
WO-2007012641-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.P.A. (IT) 2007-02-01 WO claimed
US-6319310-B1 FOR ACOUSTIC INK JET PRINTING; TRANSPARENCY, GLOSS, CREASE RESISTANCE XEROX CORPORATION 2001-11-20 US claimed
EP-0674232-B1 Recording sheets XEROX CORP (US) 2000-05-31 EP claimed
US-5663022-A Recording sheets XEROX CORPORATION (US) 1997-09-02 US claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed
EP-0674232-A2 Recording sheets XEROX CORPORATION (US) 1995-09-27 EP claimed
US-11008288-B1 Methods for preparation of apremilast NATIONAL TAIWAN NORMAL UNIVERSITY (TW) 2021-05-18 US disclosed
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
EP-1910260-B1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA SPA (IT) 2009-12-16 EP disclosed
US-7544843-B2 Process for preparing 3,4-dioxo-substituted aromatic aldehydes ENDURA S.P.A. (IT) 2009-06-09 US disclosed
US-20090062569-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES ENDURA S.P.A. (IT) 2009-03-05 US disclosed
US-6106601-A MIXTURE CONTAINING OXAZOLINE AND THIOUREA COMPOUNDS XEROX CORPORATION (US) 2000-08-22 US disclosed
US-6071333-A Ink compositions XEROX CORPORATION (US) 2000-06-06 US disclosed
US-6066200-A COMPRISING A SOLID UREA COMPOUND, AN ALCOHOL, A LIGHTFASTNESS COMPONENT, A LIGHTFAST ANTIOXIDANT, AND A COLORANT XEROX CORPORATION (US) 2000-05-23 US disclosed
US-5922117-A Ink compositions containing alcohols XEROX CORPORATION (US) 1999-07-13 US disclosed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062569-A1 PROCESS FOR PREPARING 3,4-DIOXO-SUBSTITUTED AROMATIC ALDEHYDES HAAO, AOX1, ADH1A L3MBTL1 4479/4885HTT 1989/4885CALM1 4590/4885
US-11008288-B1 Methods for preparation of apremilast APRT, ALDH3A1, TPMT L3MBTL1 4801/4885HTT 1944/4885CALM1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.